| [1] |
Sperry BW, Saeed IM, Raza S, et al. Increasing rate of hospital admissions in patients with amyloidosis(from the National Inpatient Sample)[J]. Am J Cardiol, 2019, 124(11): 1765-1769.
|
| [2] |
Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace, 2011, 13(8):1077-1109.
|
| [3] |
Sperry BW, Tang WHW. Amyloid heart disease: genetics translated into disease-modifying therapy[J]. Heart, 2017, 103(11):812-817.
|
| [4] |
程中伟，田庄，康琳，等.心脏淀粉样变患者的心电图和心脏超声特点[J].中华心血管病杂志，2010，38(7):606-609.
|
| [5] |
Tsang W, Lang RM. Echocardiographic evaluation of cardiac amyloid[J]. Curr Cardiol Rep, 2010, 12(3): 272-276.
|
| [6] |
万俊义，赵世华，蒋世良，等.心肌淀粉样变性的临床表现及MRI特征[J].中华放射学杂志，2010，44(12):1297-1299.
|
| [7] |
Syed IS, Glockner JF, Feng DL, et al. Role of cardiacmagnetic resonance imaging in the detection of cardiac amyloidosis[J]. JACC Cardiovasc Imaging, 2010, 3(2):155-164.
|
| [8] |
Mongeon FP, Jerosch-Herold M, Coelho-Filho OR, et al. Quantification of extracellular matrix expansion by CMR in infiltrative heart disease[J]. JACC Cardiovasc Imaging, 2012, 5(9):897-907.
|
| [9] |
程召平，陆敏杰，尹刚，等.纵向驰豫时间定更成像在心肌点发样变形诊断中的应用[J].中华放射学杂志，2016，50(12):935-939.
|
| [10] |
Gillmore JD, Maurer MS, Falk RH, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis[J]. Circulation, 2016, 133(24):2404-2412.
|
| [11] |
Siddiqi OK, Ruberg FL. Challenging the myths of cardiac amyloidosis[J]. Eur Heart J, 2017, 38(24):1909-1912.
|
| [12] |
Vrana JA, Gamez JD, Madden BJ, et a1. Classification of amyloidosis by laser microdissection and massspectrometry-based proteomic analysis in clinical biopsy specimens[J]. Blood, 2009, 114(24):4957-4959.
|
| [13] |
D’souza A, Dispenzieri A, Wirk B, et al. Improved outcomes after autologous hematopoietic cell transplantation for light chain amyloidosis: a center for international blood and marrow transplant research study[J]. Clin Oncol, 2015, 33(32):3741-3749.
|
| [14] |
Mehra MR, Canter CE, Hannan MM, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update[J]. J Heart Lung Transplant, 2016, 35(1):1-23.
|
| [15] |
Gray Gilstrap L, Niehaus E, Malhotra R, et al. Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis[J]. J Heart Lung Transplant, 2014, 33(2):149-156.
|
| [16] |
Shah KB, Inoue Y, Mehra MR, et al. Amyloidosisand the heart: a comprehensive review[J]. Arch Intern Med, 2006, 166(17):1805-1813.
|
| [17] |
Guan J, Mishra S, Falk RH, et al. Current perspectives on cardiac amyloidosis[J]. Am J Physiol Heart Circ Physiol, 2012, 302(3):H544-H552.
|
| [18] |
Kristen AV, Dengler TJ, Hegenbart U, et al. Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death[J]. Heart Rhythm, 2008, 5(2):235-240.
|